Peter J. Webb

750 total citations
17 papers, 454 citations indexed

About

Peter J. Webb is a scholar working on Molecular Biology, Immunology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Peter J. Webb has authored 17 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Immunology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Peter J. Webb's work include Receptor Mechanisms and Signaling (4 papers), Immune Cell Function and Interaction (3 papers) and Diabetes Treatment and Management (3 papers). Peter J. Webb is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Immune Cell Function and Interaction (3 papers) and Diabetes Treatment and Management (3 papers). Peter J. Webb collaborates with scholars based in United States, United Kingdom and Canada. Peter J. Webb's co-authors include Colin G. Brooks, Graeme Semple, Philip J. Skinner, Ruoping Chen, Jeremy G. Richman, Susan Y. Tamura, Daniel T. Connolly, Carleton R. Sage, Robert W. Baldwin and Michael F. W. Festing and has published in prestigious journals such as The Journal of Immunology, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Peter J. Webb

17 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter J. Webb United States 14 168 112 104 92 70 17 454
Tomoaki Komai Japan 10 235 1.4× 60 0.5× 95 0.9× 74 0.8× 114 1.6× 14 492
D.H. Ives United States 9 264 1.6× 49 0.4× 48 0.5× 64 0.7× 37 0.5× 11 555
Elizabeth A. Carrey United Kingdom 13 395 2.4× 77 0.7× 95 0.9× 33 0.4× 44 0.6× 25 704
L. А. Alexandrova Russia 12 325 1.9× 117 1.0× 79 0.8× 137 1.5× 19 0.3× 43 583
Xiaoqi Chen China 14 114 0.7× 43 0.4× 57 0.5× 63 0.7× 75 1.1× 38 342
Kiyean Nam United States 11 237 1.4× 146 1.3× 77 0.7× 115 1.3× 37 0.5× 24 458
Nancy S. Wang United States 5 290 1.7× 57 0.5× 105 1.0× 36 0.4× 38 0.5× 7 460
John K. Pratt United States 15 207 1.2× 134 1.2× 103 1.0× 311 3.4× 98 1.4× 23 711
Jadd R. Shelton United States 9 281 1.7× 166 1.5× 94 0.9× 163 1.8× 40 0.6× 13 521
H. Hoffman Australia 13 233 1.4× 24 0.2× 123 1.2× 31 0.3× 57 0.8× 26 586

Countries citing papers authored by Peter J. Webb

Since Specialization
Citations

This map shows the geographic impact of Peter J. Webb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Webb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Webb more than expected).

Fields of papers citing papers by Peter J. Webb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Webb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Webb. The network helps show where Peter J. Webb may publish in the future.

Co-authorship network of co-authors of Peter J. Webb

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Webb. A scholar is included among the top collaborators of Peter J. Webb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Webb. Peter J. Webb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Trzoss, Michael, Jonathan A. Covel, Mili Kapoor, et al.. (2019). Synthesis of analogs of the Gwt1 inhibitor manogepix (APX001A) and in vitro evaluation against Cryptococcus spp. Bioorganic & Medicinal Chemistry Letters. 29(23). 126713–126713. 18 indexed citations
2.
Shaw, Karen Joy, Wiley A. Schell, Jonathan A. Covel, et al.. (2018). In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus. Antimicrobial Agents and Chemotherapy. 62(8). 81 indexed citations
3.
Nambu, Mitchell D., Jonathan A. Covel, Mili Kapoor, et al.. (2017). A calcineurin antifungal strategy with analogs of FK506. Bioorganic & Medicinal Chemistry Letters. 27(11). 2465–2471. 22 indexed citations
4.
Boatman, P. Douglas, Thomas O. Schrader, Benjamin Johnson, et al.. (2010). Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a). Bioorganic & Medicinal Chemistry Letters. 20(9). 2797–2800. 23 indexed citations
5.
Skinner, Philip J., Peter J. Webb, Carleton R. Sage, et al.. (2009). 5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b. Bioorganic & Medicinal Chemistry Letters. 19(15). 4207–4209. 20 indexed citations
6.
Skinner, Philip J., Peter J. Webb, Young‐Jun Shin, et al.. (2007). Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a. Bioorganic & Medicinal Chemistry Letters. 17(20). 5620–5623. 32 indexed citations
7.
Skinner, Philip J., Peter J. Webb, Carleton R. Sage, et al.. (2007). 3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109b. Bioorganic & Medicinal Chemistry Letters. 17(23). 6619–6622. 24 indexed citations
8.
Semple, Graeme, Philip J. Skinner, Peter J. Webb, et al.. (2006). 1-Alkyl-benzotriazole-5-carboxylic Acids Are Highly Selective Agonists of the Human Orphan G-Protein-Coupled Receptor GPR109b. Journal of Medicinal Chemistry. 49(4). 1227–1230. 65 indexed citations
9.
Markgraf, J. Hodge, et al.. (2005). A versatile route to benzocanthinones. Tetrahedron. 61(38). 9102–9110. 15 indexed citations
10.
Fleming, Thomas R., et al.. (2002). Solid-Phase Organic Synthesis and Combinatorial Chemistry: A Laboratory Preparation of Oligopeptides. Journal of Chemical Education. 79(1). 85–85. 12 indexed citations
11.
Stratford, Ian J., et al.. (1991). Aziridinyl nitropyrroles and nitropyrazoles as hypoxia-selective cytotoxins and radiosensitizers.. PubMed. 6(3). 151–67. 6 indexed citations
13.
Brooks, Colin G., E A Wayner, Peter J. Webb, et al.. (1981). The specificity of rat natural killer cells and cytotoxic macrophages on solid tumor-derived target cells and selected variants.. The Journal of Immunology. 127(6). 2477–2483. 17 indexed citations
14.
Webb, Peter J. & Colin G. Brooks. (1980). Macrophage-like suppressor cells in rats. Cellular Immunology. 52(2). 370–380. 17 indexed citations
15.
Brooks, Colin G., Peter J. Webb, R. A. Robins, et al.. (1980). Studies on the immunobiology of rnu/rnu “nude” rats with congenital aplasia of the thymus. European Journal of Immunology. 10(1). 58–65. 74 indexed citations
16.
Webb, Peter J., Colin G. Brooks, & R. W. Baldwin. (1980). Macrophage-like suppressor cells in rats. Cellular Immunology. 52(2). 381–394. 13 indexed citations
17.
Brooks, Colin G., G R Flannery, Peter J. Webb, & R W Baldwin. (1980). Quantitative studies of natural immunity to solid tumours in rats. The nature of the killer cell depends on the type of assay.. PubMed. 41(3). 673–80. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026